Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.585 USD | +0.53% | +6.37% | +45.91% |
Evolution of the average Target Price on ADMA Biologics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering ADMA Biologics, Inc.
HC Wainwright | |
Mizuho Securities | |
Raymond James | |
Cantor Fitzgerald | |
Chardan |
EPS Revisions
- Stock Market
- Equities
- ADMA Stock
- Consensus ADMA Biologics, Inc.